LT - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
EN - Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/4245 |
|
|
|
A61P 3/10 |
|
|
|
A61P 7/00 |
|
|
|
A61P 9/00 |
|
European patent
| (11) |
Number of the document |
2460520 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
12152282.5 |
|
Date of filing the European patent application |
2007-10-11 |
| (97) |
Date of publication of the European application |
2012-06-06 |
| (45) |
Date of publication and mention of the grant of the patent |
2015-09-30
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
851450 P |
2006-10-12
|
US |
Inventors
| (72) |
Hirawat, Samit, US
Miller, Langdon, US
|
Grantee
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court, Middlesex Business Center, South Plainfield, NJ 07080,
US
|
Title
| (54) |
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| |
Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
